Orbimed Advisors LLC Horizon Therapeutics Public LTD CO Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $4.95 Million - $5.79 Million	-50,000 Reduced 15.8%	266,400 $30.8 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $11.2 Million - $13.1 Million	116,400 Added 58.2%	316,400 $32.5 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $3.11 Million - $3.29 Million	29,000 Added 16.96%	200,000 $21.8 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $10.7 Million - $19.5 Million	171,000 New	171,000 $19.5 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $6.99 Million - $10.2 Million	-88,000 Reduced 4.01%	2,108,555 $168 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $26.2 Million - $33.3 Million	-303,500 Reduced 12.14%	2,196,555 $231 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $10.9 Million - $13.2 Million	-110,300 Reduced 4.23%	2,500,055 $269 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $28.7 Million - $34.4 Million	-311,800 Reduced 10.67%	2,610,355 $286 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $19.2 Million - $21.3 Million	-222,200 Reduced 7.07%	2,922,155 $274 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $9.74 Million - $12.9 Million	135,600 Added 4.51%	3,144,355 $289 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $7.78 Million - $11.3 Million	140,845 Added 4.91%	3,008,755 $234 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $15.9 Million - $30 Million	526,210 Added 22.47%	2,867,910 $159 Million
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $18.9 Million - $29.3 Million	759,400 Added 47.99%	2,341,700 $69.4 Million
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $40.2 Million - $58 Million	1,582,300 New	1,582,300 $57.3 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account